Submit and Search Epigenetics Publications

1–1 of 1 record found matching your query (RSS):

Select All    Deselect All
 |   | 
  Record Links
Author (up) Garand, M.; Lin, J.H.H.; Zagorac, B.; Koschinsky, M.L.; Boffa, M.B.
url  doi
  Title Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone Type Journal Article
  Year 2013 Publication Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis Abbreviated Journal Blood Coagul Fibrinolysis  
  Volume Issue Pages  
  Abstract Thrombin-activatable fibrinolysis inhibitor (TAFI) is a pro-carboxypeptidase B-like pro-enzyme that upon activation attenuates fibrinolysis and inflammatory processes. There is a large inter-individual variability in plasma TAFI levels within the population which is primarily due to epigenetic factors. Novel associations between plasma TAFI levels and sex steroids have triggered interest in determining the role of TAFI as a mediator of the cardioprotective effects of estrogens and progestins, or as a mediator of the increased thrombotic risk that accompanies use of oral contraceptives or hormone replacement therapy (HRT). In this study, we measured the effect of sex steroids on hepatic expression of CPB2, the human gene encoding TAFI. Using human hepatocellular carcinoma cells cultured in the presence of progesterone and 17beta-estradiol, we demonstrated that the level of TAFI protein is decreased by those sex steroids. These changes in protein expression were paralleled by decreases in CPB2 mRNA abundance and promoter activity. We did not find evidence of estrogen or progesterone receptor binding sites in the CPB2 promoter region, suggesting that the genomic effects of progesterone and 17beta-estradiol are mediated indirectly, without receptor binding to the CPB2 promoter. Indeed, we found that the effect of estrogen was independent of the estrogen receptor and was mediated through a novel signaling pathway dependent on phosphatidylinositol 3-kinase and Akt that did not involve GPR30. Our findings provide the molecular explanation for the ability of female sex steroids to decrease plasma TAFI concentrations.  
  Address aDepartment of Chemistry and Biochemistry, University of Windsor, Windsor bDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0957-5235 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:23429253 Approved no  
  Call Number @ @ Serial 38051  
Permanent link to this record
Select All    Deselect All
 |   | 

Save Citations:
Export Records: